Amgen Chooses Veeva Vault CRM to Accelerate Global Medicines Delivery

Veeva Systems, a leading provider of cloud-based software for life sciences companies, announced that Amgen has decided to implement Veeva Vault CRM globally. This move aims to accelerate the delivery of innovative medicines to patients worldwide.

Amgen's Senior Vice President and Head of Information Technology, Scott Skellenger, stated, 'The transition to Vault CRM will help us speed up our efforts to provide new therapies to patients around the world faster and more flexibly.' He added that Veeva's deep understanding of the life sciences industry, its commitment to innovation, and their long-standing collaboration would support Amgen in achieving these critical goals.

Vault CRM is part of the Vault CRM Suite, a technology platform for agent-assisted commercial processes that changes how companies interact with healthcare professionals (HCPs) to accelerate market introductions and improve patient treatment outcomes. This includes the Agentic Call Report™ to generate Commercial Evidence™ and uncover previously hidden treatment barriers.

Amgen will use Veeva's platform to create a global, agent-assisted CRM foundation for commercial processes that support providing millions of patients with innovative medicines against some of the world's toughest diseases.